Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species

被引:16
作者
Nguyen, MH
Clancy, CJ
Yu, YC
Lewin, AS
机构
[1] Univ Florida, Coll Med, J Hillis Miller Hlth Ctr, Dept Med, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, J Hillis Miller Hlth Ctr, Dept Mol Genet, Gainesville, FL 32610 USA
[3] Vet Affairs Med Ctr, Dept Med, Gainesville, FL 32608 USA
关键词
D O I
10.1007/BF01700417
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The potential role of azithromycin in combination with amphotericin B against 25 clinical isolates of Aspergillus was assessed, The MIC of amphotericin B was 1 mu g/ml for 44% of the isolates, 0.5 mu g/ml for 48%, and 0.25 mu gl/ml for 8%, All isolates were resistant to azithromycin. Synergism, defined as a greater than or equal to twofold reduction in the MIC of both drugs upon combination, was demonstrated between amphotericin B and azithromycin for all 25 isolates, To prove that azithromycin exerts its antifungal effect by inhibiting protein synthesis, we studied [S-35]-methionine incorporation into protein in one Aspergillus isolate. Neither amphotericin B at 0.125 mu g/ml (fourfold below its MIC) nor azithromycin at 16 mu g/ml (greater than or equal to 16-fold below its MIC) had any effect on protein synthesis when tested alone. Upon combination, however, a 68% inhibition in protein synthesis was evident by the inhibition of [S-35]-methionine incorporation.
引用
收藏
页码:846 / 848
页数:3
相关论文
共 15 条
[1]   ACTIVITY OF AZITHROMYCIN AS A BLOOD SCHIZONTICIDE AGAINST RODENT AND HUMAN PLASMODIA IN-VIVO [J].
ANDERSEN, SL ;
AGER, A ;
MCGREEVY, P ;
SCHUSTER, BG ;
WESCHE, D ;
KUSCHNER, R ;
OHRT, C ;
ELLIS, W ;
ROSSAN, R ;
BERMAN, J .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 52 (02) :159-161
[2]   INHIBITION OF CYTOPLASMIC AND ORGANELLAR PROTEIN-SYNTHESIS IN TOXOPLASMA-GONDII - IMPLICATIONS FOR THE TARGET OF MACROLIDE ANTIBIOTICS [J].
BECKERS, CJM ;
ROOS, DS ;
DONALD, RGK ;
LUFT, BJ ;
SCHWAB, JC ;
CAO, Y ;
JOINER, KA .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01) :367-376
[3]   THE PHARMACOKINETICS AND INFLAMMATORY FLUID PENETRATION OF ORALLY-ADMINISTERED AZITHROMYCIN [J].
COOPER, MA ;
NYE, K ;
ANDREWS, JM ;
WISE, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 (04) :533-538
[4]   COMPARATIVE AND COLLABORATIVE EVALUATION OF STANDARDIZATION OF ANTIFUNGAL SUSCEPTIBILITY TESTING FOR FILAMENTOUS FUNGI [J].
ESPINELINGROFF, A ;
DAWSON, K ;
PFALLER, M ;
ANAISSIE, E ;
BRESLIN, B ;
DIXON, D ;
FOTHERGILL, A ;
PAETZNICK, V ;
PETER, J ;
RINALDI, M ;
WALSH, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :314-319
[5]  
FLEISCHER S, 1979, METHOD ENZYMOL, V56, P23
[6]   AZITHROMYCIN CONCENTRATIONS IN SINUS FLUID AND MUCOSA AFTER ORAL-ADMINISTRATION [J].
KARMA, P ;
PUKANDER, J ;
PENTTILA, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (10) :856-859
[7]  
KAZUHIRO T, 1996, ANTIMICROBIAL AGENTS, V40, P2271
[8]   ANTIMICROBIAL SUSCEPTIBILITY TESTING OF 6 CLINICAL ISOLATES OF ASPERGILLUS [J].
KITAHARA, M ;
SETH, VK ;
MEDOFF, G ;
KOBAYASHI, GS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 9 (06) :908-914
[9]   POTENTIATION OF ANTIFUNGAL EFFECTS OF ANTIBIOTICS BY AMPHOTERICIN-B [J].
KWAN, CN ;
KOBAYASHI, GS ;
SCHLESSINGER, D ;
RASKAS, HJ ;
MEDOFF, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1972, 2 (02) :61-+
[10]   ANTIFUNGAL ACTIVITY OF 4 TETRACYCLINE ANALOGS AGAINST CANDIDA-ALBICANS INVITRO - POTENTIATION BY AMPHOTERICIN-B [J].
LEW, MA ;
BECKETT, KM ;
LEVIN, MJ .
JOURNAL OF INFECTIOUS DISEASES, 1977, 136 (02) :263-270